Fengycin inhibits the growth of the human lung cancer cell line 95D through reactive oxygen species production and mitochondria-dependent apoptosis. [electronic resource]
Producer: 20131119Description: 587-98 p. digitalISSN:- 1473-5741
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Calcium -- metabolism
- Caspases -- metabolism
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cyclin D1 -- metabolism
- Cyclin-Dependent Kinase 4 -- metabolism
- Flow Cytometry
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes, Neoplasm -- drug effects
- Humans
- L-Lactate Dehydrogenase -- biosynthesis
- Lipopeptides -- pharmacology
- Lung Neoplasms -- drug therapy
- Microscopy, Confocal
- Mitochondrial Membranes -- metabolism
- Reactive Oxygen Species -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.